PMA device
Medtronic Minimed Paradigm Real-Time Revel Pump
Medtronic Minimed · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Mar 28, 2012, newest Mar 28, 2012Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
8
Naming "Minimed Paradigm Real-Time"
MAUDE reports
1
Brand "Minimed Paradigm Real-Time", since 2015
PubMed studies
6
Mentioning "Minimed Paradigm Real-Time"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic Minimed Paradigm Real-Time Revel Pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- MEDTRONIC MINIMED PARADIGM REAL-TIME REVEL PUMP, PARADIGM REAL-TIME PUMP, AND GUARDIAN REAL-TIME MONITORPMA supplement
P980022-S104 · Decided Mar 28, 2012 · 128 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Minimed Paradigm Real-Time", any status and sponsor, newest update first.
- SWITCH - Sensing With Insulin Pump Therapy to Control HbA1cPivotal-lookingCompleted
Medtronic MiniMed, Inc.Public (MDT)
NCT00598663 · 153 participants · Start Jan 2008 · Primary completion Jul 2010
Device: insulin pump with continuous glucose sensing (Paradigm Real-Time Insulin Pump System); insulin pump and blinded continuous glucose sensing (Paradigm Real-Time insulin pump) · For: Diabetes Mellitus, Type 1
Sites: Vienna, Austria; Copenhagen, Denmark; Glostrup Municipality, Denmark · 8 sites in all
- Obtain a Good Blood Glucose Control With the Paradigm Real Time SystemPivotal-lookingCompleted
Medtronic MiniMed, Inc.Public (MDT)
NCT00441129 · 115 participants · Start Jun 2006 · Primary completion May 2008
Device: Minimed paradigm Real Time Sytem; Minimed Paradigm 512/712 Insulin pump · For: Type 1 Diabetes
Sites: Caen, France; Lyon, France; Marseille, France · 8 sites in all
- Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump TherapyPivotal-lookingCompleted
Medtronic MiniMed, Inc.Public (MDT)
NCT00417989 · 485 participants · Start Jan 2007 · Primary completion Dec 2009
Device: MiniMed Paradigm REAL-Time System · For: Type 1 Diabetes
Sites: La Jolla, California; Orange, California; Boulder, Colorado · 30 sites in all
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Minimed Paradigm Real-Time", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
MW5067106 · Received Jan 6, 2017 · Event dated Sep 2, 2016
Device type: Pump, Infusion, Insulin (LZG)
Device problem as coded: Failure to Deliver; Device Displays Incorrect Message
Patient problem as coded: Dehydration; Hyperglycemia; Myocardial Infarction; Nausea; Vomiting
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722)Open, Classified
Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)Open, Classified
Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
11 more recall records with a free account
Published research
The most relevant PubMed records for "Minimed Paradigm Real-Time"[tiab]. The summary above synthesizes these.
- The integrated MiniMed Paradigm REAL-Time insulin pump and glucose monitoring system: implications for improved patient outcomes.
Mastrototaro J, Lee S · Diabetes Technol Ther · 2009
- Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study.
Mastrototaro JJ, Cooper KW, Soundararajan G, et al. · Adv Ther · 2006
- Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.
Buckingham BA, Cameron F, Calhoun P, et al. · Diabetes Technol Ther · 2013Comparative Study, Multicenter Study
- [Recent advances of monitoring and glycaemia control during early postoperative period in patients after pancreas surgery].
Lishova EA, Nikoda VV, Bondarenko AV, et al. · Anesteziol Reanimatol · 2013Clinical Trial, English Abstract
- Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D, Sulmont V, Reznik Y, et al. · Diabetes Care · 2009Multicenter Study, Randomized Controlled Trial
- Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience.
Lee SW, Sweeney T, Clausen D, et al. · J Diabetes Sci Technol · 2007
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.